Engineered MOFs and Enzymes for the Synthesis of Active Pharmaceutical Ingredients | Zendy

Cirujano Francisco G. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Engineered MOFs and Enzymes for the Synthesis of Active Pharmaceutical Ingredients

Author(s) -

Cirujano Francisco G.

Publication year - 2019

Publication title -

chemcatchem

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.497

H-Index - 106

eISSN - 1867-3899

pISSN - 1867-3880

DOI - 10.1002/cctc.201900131

Subject(s) - biocatalysis , metal organic framework , organic synthesis , chemistry , biochemical engineering , combinatorial chemistry , synthetic biology , nanotechnology , catalysis , organic chemistry , materials science , computational biology , biology , engineering , reaction mechanism , adsorption

The latest strategies in the design and synthesis of metal‐organic frameworks as heterogeneous catalysts in organic synthesis are compared with biocatalyzed transformations, as a step forward to a more convenient industrial production of pharmaceuticals. Relevant C−C and C−N bond forming reactions that are both chemo‐ and bio‐ catalyzed by synthetic MOFs and in vitro evolved and/or promiscuous enzymes with the aim of obtaining key bioactive scaffolds in a sustainable, competitive and cost‐efficient manner, are thoroughly discussed in this mini review.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research